Cardiac manifestations of HIV

Related Experiment Videos

Majid Sadigh1, Sailaja Puttagunta

  • 1Department of Medicine, St. Mary's Hospital, and Yale Primary Care Residency Program, 56 Franklin Street, Waterbury, CT 06706, USA. msadigh@stmh.org

Frontiers in Bioscience : a Journal and Virtual Library
|April 18, 2003
PubMed

Insights

Cardiac disease in HIV/AIDS patients is multifactorial, involving direct effects, viruses, and drugs. Antiretroviral therapy-induced lipodystrophy is a key risk factor for ischemic heart disease, with treatment discussed.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • HIV/AIDS Research

Background:

  • Cardiac disease in human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS) is a growing concern.
  • Pathogenesis is complex, involving direct toxic effects, viral infections, autoimmunity, nutritional deficits, and medications.
  • Clinical presentations encompass pericardial, myocardial, and valvular heart conditions.

Purpose of the Study:

  • To review the clinical manifestations of cardiac disease in HIV/AIDS.
  • To explore the role of lipodystrophy, a side effect of antiretroviral therapy (ART), in ischemic heart disease.
  • To detail the treatment strategies for lipodystrophy in this patient population.

Main Methods:

  • Literature review of cardiac manifestations in HIV/AIDS.
  • Analysis of the link between lipodystrophy and ischemic heart disease.
  • Comprehensive review of lipodystrophy treatment options.

Main Results:

  • HIV/AIDS is associated with diverse cardiac pathologies.
  • Lipodystrophy, a common complication of ART, is identified as a potential risk factor for ischemic heart disease.
  • Effective management of lipodystrophy is crucial for cardiovascular health in HIV/AIDS patients.

Conclusions:

  • Cardiac complications are significant in HIV/AIDS management.
  • Lipodystrophy management is essential to mitigate ischemic heart disease risk.
  • Further research into the multifactorial cardiac impact of HIV/AIDS and its treatment is warranted.

Related Concept Videos

Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...